logo

For the Inventor, By the Inventor

St. Peter, Germany

Manfred F Herrmann

USPTO Granted Patents = 45 

Average Co-Inventor Count = 3.0

ph-index = 7

Forward Citations = 339(Granted Patents)


Location History:

  • Saint Peter, DE (1976)
  • Gundelfingen, DE (1976 - 1978)
  • 7811 St. Peter, DE (1981)
  • 6700 Ludwigshafen, DE (1982)
  • St. Peter, DE (1976 - 1990)
  • Ulm/Donau, DE (1999)

Company Filing History:

goldMedal38 out of 2,538 
 
Warner-lambert Company
 patents
silverMedal4 out of 23 
 
Godecke Aktiengesellschaft
 patents
bronzeMedal2 out of 832,718 
Other
 patents
where one patent can have more than one assignee

Years Active: 1976-1999

Loading Chart...
45 patents (USPTO):Explore Patents
1. D406951 - Chair (1999-03-23),
2. 4933368 - N-phenylbenzamide derivatives (1990-06-12),
3. 4816485 - N-phenylbenzamide derivatives (1989-03-28),
4. 4698341 - Use of 1,6-naphthyridinone derivatives in treating pulmonary thrombosis (1987-10-06),
5. 4626546 - 3-aryl-3-pyrroline derivatives (1986-12-02),
6. 4605673 - 7H-dibenzo(a,c,)cyclohepten-5-one-(7) derivatives (1986-08-12),
7. 4598076 - 2-pyrrolin-3-carbonitril-derivatives, pharmaceutical compositions (1986-07-01),
8. 4584374 - 4-thioxo-benzopyrano[2,3-d]pyrimidine derivatives (1986-04-22),
9. 4578380 - 5H-[1]benzopyrano[2,3-d]pyrimidine derivatives useful for controlling (1986-03-25),
10. 4563471 - 4-Oxothiazolidin-2-ylidene-acetamide derivatives as CNS agents (1986-01-07),
11. 4517185 - 2-Pyrrolin-3-carbonitrile derivatives, and pharmaceutical compositions (1985-05-14),
12. 4415495 - 5,6;8,9-Tetrahydro-7H-dibenz(d,f)azonines (1983-11-15),
13. 4351640 - Dye powder formulation (1982-09-28),
14. 4294838 - Certain heterocyclic sulfoximide derivatives (1981-10-13),
15. 4284632 - 3-Pyrrolin-2-one derivatives and compositions (1981-08-18),

Title: Manfred F. Herrmann: A Pioneer in Pharmaceutical Innovations

Introduction

Manfred F. Herrmann is a renowned inventor and researcher based in St. Peter, Germany. With an impressive portfolio comprising 42 patents, his contributions have significantly impacted the field of pharmaceuticals. Discovering innovative solutions for medical challenges remains a hallmark of his career.

Latest Patents

Manfred's latest patents focus on N-phenylbenzamide derivatives, which are critical in treating refractory tumors in mammals. The derivatives described in these recent patents include the general formula I, where radicals R¹, R², and R³ can vary between hydrogen atoms or methyl radicals. These compounds, along with their pharmacologically acceptable salts, showcase potential in controlling malignant, proliferative, and autoimmune diseases, as well as in providing immunosuppressive therapy during grafting procedures.

Career Highlights

Throughout his career, Manfred F. Herrmann has worked with prestigious companies, including Warner-Lambert Company and Godecke Aktiengesellschaft. His extensive experience has enabled him to drive forward innovations that address critical health issues, leading to valuable advancements in medical treatments.

Collaborations

Manfred has collaborated with notable colleagues, including Gerhard Satzinger and Edgar Fritschi. These partnerships have fostered a rich environment for innovative thinking and have played a vital role in the development of his patented inventions.

Conclusion

Manfred F. Herrmann exemplifies the spirit of innovation in the pharmaceutical industry. With his numerous patents and collaborative efforts with esteemed colleagues, he continues to contribute significantly to advancements in medical therapies. His work not only reflects his dedication as an inventor but also underscores the importance of innovation in addressing the challenges faced in healthcare today.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…